Patient experience with follitropin alfa prefilled pen versus previously used injectable gonadotropins for ovulation induction in oligoanovulatory women

Current Medical Research and Opinion

Volumn 22, Issue 10, 2006, Pages 1981-1996

  Somkuti, Stephen G ^a   Schertz, Joan C ^b   Moore, Marva ^b   Ferrande, Lee ^b   Kelly, Eduardo ^b  

^a Abington Reproductive Medicine   (United States)

^b EMD SERONO INC   (United States)

Author keywords

Drug administration; Gonadotropins; Injections; Ovulation induction; Patient satisfaction

Indexed keywords

GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; RECOMBINANT CHORIOGONADOTROPIN ALFA; RECOMBINANT FOLLITROPIN; UNCLASSIFIED DRUG; UROFOLLITROPIN;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG SAFETY; DRUG USE; DYSMENORRHEA; ECTOPIC PREGNANCY; FEMALE; FEMALE INFERTILITY; GASTROINTESTINAL DISEASE; HUMAN; INJECTION SITE BLEEDING; INJECTION SITE BURNING; INJECTION SITE CONTUSION; INJECTION SITE ERYTHEMA; INJECTION SITE PAIN; INJECTION SITE REACTION; MAJOR CLINICAL STUDY; OPEN STUDY; OVARY HYPERSTIMULATION; OVULATION INDUCTION; PATIENT SATISFACTION; PRURITUS; TREATMENT OUTCOME;

ADULT; FEMALE; GLYCOPROTEIN HORMONES, ALPHA SUBUNIT; GONADOTROPINS; HUMANS; INJECTIONS; OVULATION INDUCTION; PATIENT SATISFACTION; PROSPECTIVE STUDIES;

EID: 33750517071     PISSN: 03007995     EISSN: None     Source Type: Journal    
DOI: 10.1185/030079906X132604     Document Type: Article

References (17)

1. Hedon B, Hugues JN, Emperaire JC, et al. A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women. Hum Reprod 1998;13:2688-92
2. Daya S. Follicle-stimulating hormone in clinical practice: an update. Treat Endocrinol 2004;3:161-71
3. Bassett RM, Driebergen R. Continued improvements in the quality and consistency of follitropin alfa, recombinant human FSH. Reprod Biomed Online 2005;10:169-77
4. Driebergen R, Baer G. Quantification of follicle stimulating hormone (follitropin alfa): is in vivo bioassay still relevant in the recombinant age? Curr Med Res Opin 2003;19:41-6
5. Calaf Alsina J, Ruiz Balda JA, Romeu Sarrio A, et al. Ovulation induction with a starting dose of 50 IU of recombinant follicle stimulating hormone in WHO group II anovulatory women: the IO-50 study, a prospective, observational, multicentre, open trial. Br J Obstet Gynaecol 2003;110:1072-7
6. Zorn JR, Coffineau A, Abirached F, et al. Acceptability and value of autoinjection of gonadotropins for ovarian stimulation in intrauterine insemination. Gynecol Obstet Fertil 2001;29:662-7
7. Lakha F, Henderson C, Glasier A. The acceptability of self-administration of subcutaneous Depo-Provera. Contraception 2005;72:14-8
8. Bahamondes L, Marchi NM, Nakagava HM, et al. Self-administration with UniJect of the once-a-month injectable contraceptive Cyclofem. Contraception 1997;56:301-4
9. Korytkowski M, Bell D, Jacobsen C, et al. A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mellitus. Clin Ther 2003;25:2836-48
10. Martin JM, Llewelyn JA, Ristic S, et al. Acceptability and safety of a new 3.0 mL re-usable insulin pen (HumaPen) in clinical use. Diabetes Nutr Metab 1999;12:306-9
11. Summers KH, Szeinbach SL, Lenox SM. Preference for insulin delivery systems among current insulin users and nonusers. Clin Ther 2004;26:1498-505
12. Bohannon NJ, Ohannesian JP, Burdan AL, et al. Patient and physician satisfaction with the Humulin/Humalog Pen, a new 3.0 mL prefilled pen device for insulin delivery. Clin Ther 2000;22:1049-67
13. Pang S, Kaplan B, Karande V, et al. Administration of recombinant human FSH (solution in cartridge) with a pen device in women undergoing ovarian stimulation. Reprod Biomed Online 2003;7:319-26
14. Kettel LM, Scholl G, Bonaventura L, et al. Evaluation of a pen device for self-administration of recombinant human FSH in clomiphene citrate-resistant anovulatory women undergoing ovulation induction. Reprod Biomed Online 2004;9:373-80
15. Platteau P, Laurent E, Albano C, et al. An open, randomized single-centre study to compare the efficacy and convenience of follitropin beta administered by a pen device with follitropin alpha administered by a conventional syringe in women undergoing ovarian stimulation for IVF/ICSI. Hum Reprod 2003;18:1200-4
16. Craenmehr E, Bontje PM, Hoomans E, et al. Follitropin-beta administered by pen device has superior local tolerance compared with follitropin-alpha administered by conventional syringe. Reprod Biomed Online 2001;3:185-9
17. D'Eliseo PD, Blaauw J, Millicevic Z, et al. Patient acceptability of a new 3.0 mL pre-filled insulin pen. Curr Med Res Opin 2000;16:125-33